DHA, for example, significantly reduces fatty acid synthase (FASN) expression in cancer cells, inhibiting ZDHHC5 activity and promoting the degradation of PD-L1 via the CSN5-dependent ubiquitin-proteasome pathway (Fig. 4B) (62). This evidence concerns the gene ZDHHC5 and cancer.